K. O. ’. Connell

Regional infusion of a class C TLR9 agonist enhances liver tumor microenvironment reprogramming and MDSC reduction to improve responsiveness to systemic checkpoint inhibition

S. Katz, B. Cox, P. Guha, 2022, Cancer gene therapy.